NxStage Medical, Inc. (NXTM) [Rocket]

In millions, except per share items	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13	Dec-31-12	Dec-31-11	Dec-31-10
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
System One	301.3	276.4	247.8	212.6	176.8	163.1	143.5	113.9
In-Center	61.3	63.0	74.8	78.9	81.9	76.9	73.8	65.4
Services	19.5	14.8	6.4	1.7	0.4
Other	11.8	12.2	10.3	8.3	4.5	2.1
Other	1.4					4.3
Total revenues [+]	395.4	365.1	334.7	301.5	263.4	246.4	217.3	179.2
Products	393.9	366.4	336.1	301.5	263.4	242.1		179.2
Other	1.4	-1.3	-1.4
Revenue growth [+]	8.3%	9.1%	11.0%	14.5%	6.9%	13.4%	21.2%	20.5%
System One	9.0%	11.5%	16.6%	20.3%	8.4%	13.7%	26.0%	32.7%
In-Center	-2.7%	-15.7%	-5.2%	-3.6%	6.4%	4.3%	12.9%	4.0%
Services	32.2%	130.5%	266.6%	396.9%
Other	-3.0%	18.1%	24.4%	85.3%	115.3%
Cost of goods sold [+]	258.1	243.0	230.9	185.6	160.9	149.3	139.6	121.1
Cost of product sales	225.7	214.4	204.7
Transportation costs	32.5	28.6	26.2
Gross profit	137.2	122.1	103.8	115.9	102.5	97.1	77.6	58.1
Gross margin	34.7%	33.5%	31.0%	38.4%	38.9%	39.4%	35.7%	32.4%
Selling, general and administrative [+]	110.0	96.7	93.7	89.5	80.2	68.0	37.6	56.9
Sales and marketing	68.2	63.9	58.5	55.4	47.8	40.5	37.6	34.2
General and administrative	41.8	32.8	35.1	34.1	32.3	27.5		22.8
Other selling, general and administrative
Research and development	39.6	31.0	26.2	22.6	18.9	17.1		12.9
Other operating expenses	1.4	-1.3	-1.4	26.0	21.2	23.2	65.6	14.8
EBITDA [+]	19.9	28.4	16.1	5.5	7.1	12.5	-2.4	-4.1
EBITDA growth	-29.8%	76.3%	191.9%	-21.8%	-43.5%	-615.6%	-40.8%	-73.9%
EBITDA margin	5.0%	7.8%	4.8%	1.8%	2.7%	5.1%	-1.1%	-2.3%
Depreciation	31.8	30.6	28.1	24.9	22.0	20.9	20.3	19.6
EBITA	-11.9	-2.3	-12.0	-19.4	-15.0	-8.4	-22.7	-23.7
EBITA margin	-3.0%	-0.6%	-3.6%	-6.4%	-5.7%	-3.4%	-10.5%	-13.2%
Amortization of intangibles	2.0	2.0	2.6	2.8	2.8	2.8	2.8	2.8
EBIT [+]	-13.9	-4.3	-14.6	-22.2	-17.8	-11.2	-25.5	-26.5
EBIT growth	223.2%	-70.7%	-34.1%	24.7%	58.8%	-56.1%	-3.6%	-27.4%
EBIT margin	-3.5%	-1.2%	-4.4%	-7.4%	-6.8%	-4.5%	-11.7%	-14.8%
Interest expense	0.6	0.6	0.7	0.9	0.6	2.8		4.6
Interest expense	0.6	0.6	0.7	0.9	0.6	2.8	4.7	4.6
Other income (expense), net [+]	-1.0	-1.3	0.1	0.0	-0.4	-0.1	9.7	0.1
Gain (loss) on foreign currency transactions								0.5
Other	-0.9	-0.9	0.6	0.0	-0.4	-0.1	-5.0	0.1
Pre-tax income	-15.5	-6.2	-15.2	-23.1	-18.8	-14.1	-20.5	-30.9
Income taxes	-0.1	1.1	1.1	1.3	-0.2	1.0	0.9	0.8
Tax rate	0.9%				1.3%
Minority interest	-1.3	-2.5	-0.9	-0.4
Net income	-14.5	-4.8	-15.3	-23.9	-18.6	-15.2	0.0	-31.7
Net margin	-3.7%	-1.3%	-4.6%	-7.9%	-7.0%	-6.1%	0.0%	-17.7%

Basic EPS [+]	($0.22)	($0.07)	($0.24)	($0.39)	($0.31)	($0.26)	$0.00	($0.66)
Growth	197.2%	-69.4%	-37.6%	26.0%	17.7%		-100.0%	-29.4%
Diluted EPS [+]	($0.22)	($0.07)	($0.24)	($0.39)	($0.31)	($0.26)	$0.00	($0.66)
Growth	197.2%	-69.4%	-37.6%	26.0%	17.7%		-100.0%	-29.4%

Shares outstanding (basic) [+]	65.9	64.5	63.4	61.7	60.3	57.9	54.2	48.2
Growth	2.1%	1.8%	2.7%	2.4%	4.1%	6.8%	12.5%	3.3%
Shares outstanding (diluted) [+]	65.9	64.5	63.4	61.7	60.3	57.9	54.2	48.2
Growth	2.1%	1.8%	2.7%	2.4%	4.1%	6.8%	12.5%	3.3%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.